Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Current role for combination therapy in male LUTS.

Chung DE, Kaplan SA.

Arch Esp Urol. 2010 Jun;63(5):323-32. Review. English, Spanish.

PMID:
20587837
2.

The role of combination medical therapy in benign prostatic hyperplasia.

Greco KA, McVary KT.

Int J Impot Res. 2008 Dec;20 Suppl 3:S33-43. doi: 10.1038/ijir.2008.51. Review.

PMID:
19002123
3.

BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE.

Roehrborn CG.

BJU Int. 2008 Mar;101 Suppl 3:17-21. doi: 10.1111/j.1464-410X.2008.07497.x. Review.

4.

Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.

Logan YT, Belgeri MT.

Am J Geriatr Pharmacother. 2005 Jun;3(2):103-14. Review.

PMID:
16129387
5.

Inhibitors of 5alpha-reductase in the treatment of benign prostatic hyperplasia.

Tarter TH, Vaughan ED Jr.

Curr Pharm Des. 2006;12(7):775-83. Review.

PMID:
16515494
6.

Does the combination of an alpha1-adrenergic antagonist with a 5alpha-reductase inhibitor improve urinary symptoms more than either monotherapy?

Hollingsworth JM, Wei JT.

Curr Opin Urol. 2010 Jan;20(1):1-6. doi: 10.1097/MOU.0b013e3283336f96. Review.

PMID:
19881352
7.

Current status of 5alpha-reductase inhibitors in the treatment of benign hyperplasia of prostate.

Kumar VL, Wahane VD.

Indian J Med Sci. 2008 Apr;62(4):167-75. Review.

PMID:
18445985
8.
11.
12.

A review of combination therapy in patients with benign prostatic hyperplasia.

McVary KT.

Clin Ther. 2007 Mar;29(3):387-98. Review.

PMID:
17577460
13.

[Combination therapy in benign prostatic hyperplasia (BPH)].

Desgrandchamps F.

Ann Urol (Paris). 2004 Dec;38 Suppl 2:S24-8. Review. French.

PMID:
15651487
14.

Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: therapeutic options for the man at risk.

Emberton M, Zinner N, Michel MC, Gittelman M, Chung MK, Madersbacher S.

BJU Int. 2007 Aug;100(2):249-53. Review.

15.

Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?

Silva J, Silva CM, Cruz F.

Curr Opin Urol. 2014 Jan;24(1):21-8. doi: 10.1097/MOU.0000000000000007. Review.

PMID:
24231531
16.
17.

[Pharmacological treatment of benign prostatic hyperplasia].

Oelke M, Kuczyk MA, Herrmann TR.

Urologe A. 2009 Nov;48(11):1365-75; quiz 1376-7. doi: 10.1007/s00120-009-2141-y. German.

PMID:
19851747
18.
19.

[Medical treatment of voiding problems in men].

Andersen JT, Nordling J, Walter S.

Ugeskr Laeger. 2007 May 14;169(20):1892-4. Danish.

PMID:
17553364
20.

Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.

Gallegos PJ, Frazee LA.

Pharmacotherapy. 2008 Mar;28(3):356-65. doi: 10.1592/phco.28.3.356. Review.

PMID:
18294115

Supplemental Content

Support Center